Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hammond

Showing results (691-700 of 711) with videos related to

Pageof 72
Sort By:
Nature Communications|January 24, 2024
Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunityIsaac Dean, Colin Y C Lee, Zewen K Tuong, et al.
Journal for Immunotherapy of Cancer|August 4, 2025
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine releaseMiguel Gaspar, Marina Natoli, Laure Castan, et al.
Cell|February 13, 2001
Interleukin 20: discovery, receptor identification, and role in epidermal functionH Blumberg, D Conklin, W F Xu, et al.
Scientific Reports|November 9, 2019
Viral emergence in marine mammals in the North Pacific may be linked to Arctic sea ice reductionE VanWormer, J A K Mazet, A Hall, et al.
American Journal of Epidemiology|July 14, 2011
The PhenX Toolkit: get the most from your measuresCarol M Hamilton, Lisa C Strader, Joseph G Pratt, et al.
The Journal of Biological Chemistry|February 23, 2010
A proprotein convertase subtilisin-like/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density lipoprotein uptakeYan G Ni, Jon H Condra, Laura Orsatti, et al.
Current Oncology (Toronto, Ont.)|August 2, 2013
The epidemic of human papillomavirus and oropharyngeal cancer in a Canadian populationA C Nichols, D A Palma, S S Dhaliwal, et al.
Nature Immunology|July 31, 2019
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Nature Immunology|September 26, 2019
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Journal of Lipid Research|October 21, 2010
A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivoYan G Ni, Stefania Di Marco, Jon H Condra, et al.
Pageof 72

Showing results (691-700 of 711) with videos related to

Sort By:
Pageof 72
Nature Communications|January 24, 2024
Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunityIsaac Dean, Colin Y C Lee, Zewen K Tuong, et al.
Journal for Immunotherapy of Cancer|August 4, 2025
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine releaseMiguel Gaspar, Marina Natoli, Laure Castan, et al.
Cell|February 13, 2001
Interleukin 20: discovery, receptor identification, and role in epidermal functionH Blumberg, D Conklin, W F Xu, et al.
Scientific Reports|November 9, 2019
Viral emergence in marine mammals in the North Pacific may be linked to Arctic sea ice reductionE VanWormer, J A K Mazet, A Hall, et al.
American Journal of Epidemiology|July 14, 2011
The PhenX Toolkit: get the most from your measuresCarol M Hamilton, Lisa C Strader, Joseph G Pratt, et al.
The Journal of Biological Chemistry|February 23, 2010
A proprotein convertase subtilisin-like/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density lipoprotein uptakeYan G Ni, Jon H Condra, Laura Orsatti, et al.
Current Oncology (Toronto, Ont.)|August 2, 2013
The epidemic of human papillomavirus and oropharyngeal cancer in a Canadian populationA C Nichols, D A Palma, S S Dhaliwal, et al.
Nature Immunology|July 31, 2019
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Nature Immunology|September 26, 2019
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Journal of Lipid Research|October 21, 2010
A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivoYan G Ni, Stefania Di Marco, Jon H Condra, et al.
Pageof 72